Validity of Quality of Life Measurement Tools - From Generic to Disease-specific

被引:55
作者
Wells, George A. [1 ]
Russell, Anthony S.
Haraoui, Boulos
Bissonnette, Robert [2 ]
Ware, Carl F.
机构
[1] Univ Ottawa, Inst Heart, Cardiovasc Res Methods Ctr, Ottawa, ON K1Y 4W7, Canada
[2] Innovaderm Res, Montreal, PQ, Canada
关键词
HEALTH-RELATED QUALITY OF LIFE; RESPONSIVENESS; RELIABILITY; GENERIC MEASUREMENT INSTRUMENTS; DISEASE-SPECIFIC; CLINICAL-TRIALS; HEALTH-STATUS; EQ-5D; RELIABILITY; FRAMEWORK; INDEX; SF-36;
D O I
10.3899/jrheum.110906
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Health-related quality of life (HRQOL) is an important measure of a patient's perception of his/her illness. Over the past 3 decades, numerous instruments have been developed to measure HRQOL in various patient populations, with 2 basic approaches: generic and disease-specific. While generic measures have broad application across different types and severity of diseases, disease-specific measures are designed to assess particular diseases or patient populations. All HRQOL instruments, however, must be valid and have high reliability and responsiveness. Validity ensures that the instrument measures what it is supposed to measure. Reliable instruments are able to reproducibly differentiate between subjects. Responsive evaluative measures are able to detect important changes in HRQOL during a period of time, even if those changes are small. HRQOL measures should also be interpretable, meaning that the differences in scores that correspond to small, moderate, and large HRQOL changes are easily identifiable. This article describes the steps in the development of HRQOL instruments from the conceptual framework to creation and testing. Several examples of generic and disease-specific instruments commonly used to evaluate HRQOL in patients with immune-mediated inflammatory diseases (IMID) are provided. (J Rheumatol 2011;38 Suppl 88:2-6; doi:10.3899/jrheum.110906)
引用
收藏
页码:2 / 6
页数:5
相关论文
共 29 条
[21]  
Sprawls P., PHYS PRINCIPLES MED, P1
[22]   Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample [J].
Sullivan, Patrick W. ;
Ghushchyan, Vahram .
MEDICAL DECISION MAKING, 2006, 26 (04) :401-409
[23]  
The Health Measurement Research Group, HLTH REL QUAL LIF ME
[24]   RELIABILITY COEFFICIENT FOR MAXIMUM LIKELIHOOD FACTOR-ANALYSIS [J].
TUCKER, LR ;
LEWIS, C .
PSYCHOMETRIKA, 1973, 38 (01) :1-10
[25]   OMERACT: An international initiative to improve outcome measurement in rheumatology [J].
Tugwell, Peter ;
Boers, Maarten ;
Brooks, Peter ;
Simon, Lee ;
Strand, Vibeke ;
Idzerda, Leanne .
TRIALS, 2007, 8 (1)
[26]   Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D [J].
Walters, SJ ;
Brazier, JE .
QUALITY OF LIFE RESEARCH, 2005, 14 (06) :1523-1532
[27]   What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D [J].
Stephen J Walters ;
John E Brazier .
Health and Quality of Life Outcomes, 1 (1)
[28]   THE MOS 36-ITEM SHORT-FORM HEALTH SURVEY (SF-36) .1. CONCEPTUAL-FRAMEWORK AND ITEM SELECTION [J].
WARE, JE ;
SHERBOURNE, CD .
MEDICAL CARE, 1992, 30 (06) :473-483
[29]  
WILLIAMS A, 1990, HEALTH POLICY, V16, P199